全文获取类型
收费全文 | 3590篇 |
免费 | 234篇 |
国内免费 | 95篇 |
专业分类
耳鼻咽喉 | 83篇 |
儿科学 | 72篇 |
妇产科学 | 66篇 |
基础医学 | 380篇 |
口腔科学 | 39篇 |
临床医学 | 254篇 |
内科学 | 416篇 |
皮肤病学 | 35篇 |
神经病学 | 294篇 |
特种医学 | 254篇 |
外科学 | 461篇 |
综合类 | 502篇 |
预防医学 | 283篇 |
眼科学 | 54篇 |
药学 | 300篇 |
1篇 | |
中国医学 | 89篇 |
肿瘤学 | 336篇 |
出版年
2024年 | 9篇 |
2023年 | 77篇 |
2022年 | 111篇 |
2021年 | 145篇 |
2020年 | 109篇 |
2019年 | 100篇 |
2018年 | 150篇 |
2017年 | 132篇 |
2016年 | 117篇 |
2015年 | 109篇 |
2014年 | 298篇 |
2013年 | 249篇 |
2012年 | 198篇 |
2011年 | 236篇 |
2010年 | 184篇 |
2009年 | 177篇 |
2008年 | 184篇 |
2007年 | 156篇 |
2006年 | 154篇 |
2005年 | 106篇 |
2004年 | 77篇 |
2003年 | 89篇 |
2002年 | 67篇 |
2001年 | 68篇 |
2000年 | 69篇 |
1999年 | 56篇 |
1998年 | 38篇 |
1997年 | 37篇 |
1996年 | 38篇 |
1995年 | 44篇 |
1994年 | 31篇 |
1993年 | 31篇 |
1992年 | 30篇 |
1991年 | 26篇 |
1990年 | 6篇 |
1989年 | 24篇 |
1988年 | 14篇 |
1987年 | 14篇 |
1986年 | 18篇 |
1985年 | 18篇 |
1984年 | 15篇 |
1983年 | 7篇 |
1982年 | 14篇 |
1981年 | 15篇 |
1980年 | 10篇 |
1979年 | 9篇 |
1978年 | 15篇 |
1977年 | 5篇 |
1973年 | 11篇 |
1972年 | 8篇 |
排序方式: 共有3919条查询结果,搜索用时 31 毫秒
1.
Whitney S. Brandt Wanpu Yan Jian Zhou Kay See Tan Joseph Montecalvo Bernard J. Park Prasad S. Adusumilli James Huang Matthew J. Bott Valerie W. Rusch Daniela Molena William D. Travis Mark G. Kris Jamie E. Chaft David R. Jones 《The Journal of thoracic and cardiovascular surgery》2019,157(2):743-753.e3
Objective
Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.Methods
Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.Results
In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.Conclusions
Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection. 相似文献2.
《Seminars in Arthroplasty》2015,26(1):28-33
While use of large heads in total hip arthroplasty (THA) continues to grow, concerns have been raised regarding anterior hip pain resulting from impingement of the prosthetic head against soft-tissues like the iliopsoas. To address these concerns, a new anatomically contoured head (ACH) was developed. In this study cadaver tests were utilized to show that iliopsoas impingement/tenting caused by conventional heads is significantly relieved with the more rounded and reduced distal profile of the ACH. Thus, the ACH implant may be able to decrease the risk of soft-tissue impingement with conventional heads, particularly in the smaller hip. 相似文献
3.
Matthew D. Li Katrina F. Chu Allegra DePietro Vincent Wu Eric Wehrenberg-Klee Omar Zurkiya Raymond W. Liu Suvranu Ganguli 《Journal of vascular and interventional radiology : JVIR》2019,30(3):314-319
Purpose
To evaluate the feasibility of a same-day yttrium-90 (90Y) radioembolization protocol with resin microspheres (including pretreatment angiography, lung shunt fraction [LSF] determination, and radioembolization) for the treatment of hepatocellular carcinoma (HCC) and liver metastases.Materials and Methods
All same-day radioembolization procedures performed over 1 y (February 2017 to January 2018) were included in this single-institutional retrospective analysis, in which 34 procedures were performed in 26 patients (median age, 63 y; 13 women), 19 with liver metastases and 7 with HCC. Yttrium-90 treatment activities were calculated by body surface area method. Tumor imaging response was assessed by Response Evaluation Criteria In Solid Tumors (RECIST) 1.1 for liver metastases and modified RECIST for HCC. Clinical side effects and adverse events were graded per Common Terminology Criteria for Adverse Events version 4.0.Results
All planned cases were technically successful, and no cases were canceled for elevated LSF or vascular anatomic reasons. Pretreatment angiography modified the planned 90Y treatment activity in 1 case in which vascular anatomy required a lobar-dose split into 2 for segmental infusions. In 18% of cases, patients were briefly admitted after the procedure for observation or symptom management. Imaging evaluation of initial efficacy at 1 month demonstrated partial response in 25% and stable disease in 67% of patients with liver metastases and partial/complete response in 43% and stable disease in 14% of patients with HCC. Grade ≥ 3 adverse events occurred in 6% of cases, with no systemic therapy–limiting toxicities. The mean total procedure time was 4.2 hours.Conclusions
A same-day 90Y radioembolization protocol with resin microspheres is feasible in select patients, which can expedite cancer therapy. 相似文献4.
目的 观察SWIM技术治疗后循环大血管闭塞所致急性缺血性卒中的有效性及安全性。
方法 回顾性分析2017年2月-2018年11月于大连市中心医院采用SWIM技术治疗的后循环大血管闭
塞所致急性缺血性卒中患者的临床资料,评价该技术的疗效和安全性,并分析影响患者预后的因素。
观察指标为术后即刻成功再通(mTICI≥2b)、90 d良好预后(mRS评分≤2分),以及术后24 h任何颅内
出血、90 d全因死亡。
结果 共纳入35例患者,平均年龄66.1±12.1岁,男性26例(74.3%),基线NIHSS评分22(15~34)分。
术后即刻成功再通率为94.3%(33/35),90 d良好预后率为45.7%(16/35),24 h颅内出血率为17.1%
(6/35),90 d全因死亡率为37.1%(13/35)。单因素分析显示,基线NIHSS评分较低(P =0.001)、基
线后循环ASPECTS评分较高(P =0.016)、发病至到院时间较短(P =0.039)、发病至再通时间较短
(P =0.047)、血管成功再通率较高(P =0.036)以及饮酒比例较低(P =0.042)与良好预后相关。
结论 使用SWIM技术治疗后循环急性缺血性卒中相对安全、有效。 相似文献
5.
目的 定性了解矿山巷道内气溶胶的浓度和粒径分布特性。方法 在巷道内的不同区间,分别用凝结核颗粒计数器和个人气溶胶测量仪巡测气溶胶的粒子数和质量浓度,并通过质量浓度的分级测量定性评价微米级气溶胶的粒径分布;在调度室内外,用金属丝网筛扩散法测量亚微米级气溶胶的粒径分布。结果 巷道内可吸入颗粒物(PM10)的平均质量浓度为0.42 mg/m3,其量值大小因工作断面而异,且受人工活动影响变化较大;巷道内粒径大于1.0 μm的颗粒物广泛存在,而粒子直径小于5 nm的气溶胶基本上未被检出。结论 矿山巷道内气溶胶特性因工作断面、人工活动和通风条件的不同而变化明显,在开展内照射剂量评价时应考虑粒径大于1.0 μm放射性气溶胶粒子的剂量贡献。 相似文献
6.
目的 观察急性大血管闭塞性轻型卒中患者血管内治疗的疗效及安全性。
方法 回顾性分析2018年1月-2019年5月行血管内治疗的急性大血管闭塞性轻型卒中(NIHSS评分
≤5分)患者的临床资料。观察术后血管成功再通率(mTICI≥2b级)、围手术期并发症、90 d良好预后率
(mRS评分≤2分)等。
结果 共纳入13例患者,平均年龄58.7±14.5岁,男性11例(84.6%)。术后血管成功再通率100%;围
手术期并发症2例,假性动脉瘤1例、无症状性颅内出血1例;90 d良好预后率100%。
结论 急性大血管闭塞性轻型卒中行血管内治疗可能是安全、有效的。 相似文献
7.
L. Rosenberg M.D. I. T. Jackson D. Sharpe J. Weiss 《European journal of plastic surgery》1987,9(4):158-159
Summary A system which can be used for injection or infiltration of large volumes of fluid is described. This consists of a syringe which fills automatically from a reservoir through an inlet/outlet valve. 相似文献
8.
因症就诊检出早期大肠癌的临床及病理学特征 总被引:1,自引:0,他引:1
目的探讨在就诊的肛肠病人中如何提高早期大肠癌的检出率。方法在11家医院推广对肛肠病人的四项检查程序——直肠指检,乙结镜检查,大便隐血试验,和X线气钡灌肠造影。结果在4821例有肛肠症状的病人中,检出大肠癌188例,检出率为3.9%,其中180例有术后病理诊断。47/180例(26.1%)属早期癌(DukesstageA)。41/47例由上述四项检查作出初步诊断。初发症状为:(1)便血(26例,持续15.2±9.4周后就诊,肿瘤平均直径2.58cm);(2)大便习惯改变(9例,33.4±19.7周,3.39cm);(3)腹痛腹块(10例,19.2±11.2周,5.0cm);(4)贫血(2例,17.2±9.9周,4.75cm)。8/12例的A0和A1期病例属便血组,并多位于直肠。41/47例以高、中分化腺癌为主,其中15例伴有腺瘤癌变。术前曾作活检的27例中,12例未检出癌变细胞。结论四项检查对检出早期大肠癌是有效的,便血是提示早期癌最有价值的症状,加强大肠癌防治宣教,采用瘤灶多点或全瘤活检技术,高度重视大肠腺瘤和不典型增生等癌前病变,将有助于提高早期大肠癌的检出率 相似文献
9.
10.
天然放射性气溶胶粒径分布的变化会引起氡及其子体所致肺剂量的较大涨落。由于我国对其报道甚少,在肺剂量估算中均引用UNSCEAR的推荐值。为验证这种引用的合理性和建立气溶胶粒径分布的测量方法,开展本项研究。方法采用金属丝网筛(165目)扩散法测量天然空气经不同数目网筛扩散前后的放射性浓度比(衰减比)来绘制衰减曲线,然后用池边模式计算出粒径分布曲线。衰减比、粒径分布的计算和曲线的绘制均采用计算机。结果室内外天然放射性气溶胶粒径呈几何正态分布,分布的峰值的平均值分别为(0.20±0.09)μm和(0.27±0.11)μm。粒径分布和氡浓度、气压、气温、湿度等未发现相关关系。结论本研究结果与UNSCEAR报告书(1988)的推荐值相比,室内值相同,室外值略高,与Jacobi的研究相近。由此可得出结论,福州地区引用UNSCEAR报告书的推荐值来估算氡及其子体所致肺剂量是合适的。此结论能否推广到其他地区,还需作进一步的研究。 相似文献